Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Irritable Bowel Syndrome, September 2024 Free Subscription Abstracts Retrieve all available abstracts of the following 98 articles: HTML format

Single Articles

1. MAHURKAR-JOSHI S, Shera S, Labus J, Dong TS, et al
   Sex Differences in Colonic Mucosal Microbiome of Irritable Bowel Syndrome Patients Compared to Healthy Controls.
   medRxiv [Preprint]. 2024 Aug 2:2024.07.31.24311317.
   PubMed    
   Abstract available
   
   

2. LABUS JS, Delgadillo DR, Cole S, Wang C, et al
   IBS stress reactivity phenotype is associated with blood transcriptome profiles and microstructural and functional brain changes.
   medRxiv [Preprint]. 2024 Aug 8:2024.08.07.24311369.
   PubMed    
   Abstract available
   
   

3. CASTEELS P, Kindt S
   Diagnosing and managing irritable bowel syndrome with predominant diarrhoea in clinical practice: online survey among gastroenterologists and general practitioners.
   Acta Gastroenterol Belg. 2024;87:229-234.
   PubMed    
   Abstract available
   
   

4. CHAVAN S, Bhuvad S, Gupta V, Deshmukh V, et al
   Industrial manufacturing method and characterization of Ayurvedic marine drugs: mother pearl, cowry, coral and pearl.
   Drug Dev Ind Pharm. 2024 Aug 29:1-14. doi: 10.1080/03639045.2024.2396902.
   PubMed    
   Abstract available
   
   

5. TETALI B, Chey WD, Menees SB
   Missed Opportunity to Triage Patients with Irritable Bowel Syndrome to Multidisciplinary Therapy.
   Clin Gastroenterol Hepatol. 2024 Aug 27:S1542-3565(24)00788.
   PubMed    
   
   
   

6. WU H, Liu Q, Liu J, Liu M, et al
   Effects of neuroticism on pre-exam irritable bowel syndrome in female middle school students: mediating role of intolerance of uncertainty and moderating role of exercise duration.
   Front Psychiatry. 2024;15:1420970.
   PubMed    
   Abstract available
   
   

7. LINSALATA M, Ignazzi A, D'Attoma B, Riezzo G, et al
   Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet.
   Nutrients. 2024;16:2706.
   PubMed    
   Abstract available
   
   

8. LI C, Li J, Zhou Q, Wang C, et al
   Effects of Physical Exercise on the Microbiota in Irritable Bowel Syndrome.
   Nutrients. 2024;16:2657.
   PubMed    
   Abstract available
   
   

9. AFFAITATI G, Costantini R, Fiordaliso M, Giamberardino MA, et al
   Pain from Internal Organs and Headache: The Challenge of Comorbidity.
   Diagnostics (Basel). 2024;14:1750.
   PubMed    
   Abstract available
   
   

10. HOWARD A, Carroll-Portillo A, Alcock J, Lin HC, et al
    Dietary Effects on the Gut Phageome.
    Int J Mol Sci. 2024;25:8690.
    PubMed    
    Abstract available
    
    

11. BRICK C, Su H, Taylor K, Burgell R, et al
    Moving beyond Symptom Criteria to Diagnose and Treat Functional Disorders: Patient-Reported Symptoms of Functional Lower Gastrointestinal Disorders Correlate Poorly with Objective Assessment of Luminal Contents Seen on Intestinal Ultrasound.
    J Clin Med. 2024;13:4759.
    PubMed    
    Abstract available
    
    

12. MARASCO G, Bruni A, Nardone OM, Lopetuso LR, et al
    Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey.
    J Clin Med. 2024;13:4749.
    PubMed    
    Abstract available
    
    

13. ROTARU M, Singeap AM, Ciobica A, Huiban L, et al
    Oral Health and "Modern" Digestive Diseases: Pathophysiologic and Etiologic Factors.
    Biomedicines. 2024;12:1854.
    PubMed    
    Abstract available
    
    

14. ZHENG W, Pang K, Min Y, Wu D, et al
    Prospect and Challenges of Volatile Organic Compound Breath Testing in Non-Cancer Gastrointestinal Disorders.
    Biomedicines. 2024;12:1815.
    PubMed    
    Abstract available
    
    

15. TATE AR, Rao GHR
    Inflammation: Is It a Healer, Confounder, or a Promoter of Cardiometabolic Risks?
    Biomolecules. 2024;14:948.
    PubMed    
    Abstract available
    
    

16. ANDRADE C
    Therapeutic Effects, Side Effects, and Adverse Effects of Neuropsychiatric Drugs in the Context of Treating Cancer-Related Anorexia With Olanzapine and Mirtazapine.
    J Clin Psychiatry. 2024;85:24f15532.
    PubMed    
    Abstract available
    
    

17. GROVER M
    Insights Into the Role of the Microbiome in Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2024;20:352-354.
    PubMed    
    
    
    

18. KIM HK, Kim H, Lee A
    Attributes of multiple concurrent functional gastrointestinal disorders in female university students in South Korea.
    Women Health. 2024;64:674-686.
    PubMed    
    Abstract available
    
    

19. SHAIDULLOV I, Bouchareb D, Sorokina D, Sitdikova G, et al
    Nitric oxide in the mechanisms of inhibitory effects of sodium butyrate on colon contractions in a mouse model of irritable bowel syndrome.
    Naunyn Schmiedebergs Arch Pharmacol. 2024.
    PubMed    
    Abstract available
    
    

20. HARTIKAINEN AK, Jalanka J, Lahtinen P, Ponsero AJ, et al
    Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients.
    NPJ Biofilms Microbiomes. 2024;10:73.
    PubMed    
    Abstract available
    
    

21. TEASDALE E, Everitt H, Alderson S, Ford A, et al
    Low-dose amitriptyline for irritable bowel syndrome (IBS): a qualitative study of patients' and GPs' views and experiences.
    Br J Gen Pract. 2024 Aug 27:BJGP.2024.0303. doi: 10.3399/BJGP.2024.0303.
    PubMed    
    Abstract available
    
    

22. LI Y, Turroni S, Gong L, Shi D, et al
    Editorial: Interaction between the gut flora and immunity in intestinal diseases.
    Front Immunol. 2024;15:1458526.
    PubMed    
    
    
    

23. ALMANSOUR O
    Prevalence of Irritable Bowel Syndrome (IBS) in the Arab World: A Systematic Review.
    Cureus. 2024;16:e65421.
    PubMed    
    Abstract available
    
    

24. LUO M, Liu J, Zhang Z, Tao J, et al
    Diagnostic accuracy of a simplified tool for irritable bowel syndrome with predominant constipation in Chinese patients: A multicenter, prospective, observational study.
    Chin Med J (Engl). 2024 Aug 26. doi: 10.1097/CM9.0000000000003246.
    PubMed    
    
    
    

25. MA J, Zhang J, Zhang Y, Wang Z, et al
    Causal effects of noise and air pollution on multiple diseases highlight the dual role of inflammatory factors in ambient exposures.
    Sci Total Environ. 2024;951:175743.
    PubMed    
    Abstract available
    
    

26. LU Q, Yang H, Feng S, Xie X, et al
    Establishment of a UPLC-MS method for quantitative analysis of tryptophan-kynurenine metabolism in IBS-D model rats.
    J Pharm Biomed Anal. 2024;251:116426.
    PubMed    
    Abstract available
    
    

27. LAMBIASE C, Bellini M
    SUDD, post-diverticulitis pain and IBS: are they really different?
    Intern Emerg Med. 2024;19:1209-1210.
    PubMed    
    
    
    

28. ZHANG X, Shi L, Chen C, Ma Y, et al
    The role of miRNA in IBS pathogenesis, diagnosis and therapy: The latest thought.
    Dig Liver Dis. 2024;56:1433-1441.
    PubMed    
    Abstract available
    
    

29. HANSEN E, Peter B, Wolf TG
    Editorial: Clinical hypnosis.
    Front Psychol. 2024;15:1464449.
    PubMed    
    
    
    

30. ESCODA T, Retornaz F, Plauzolles A, Halfon P, et al
    [SIBO, from myth to reality].
    Rev Med Interne. 2024 Sep 4:S0248-8663(24)00735.
    PubMed    
    Abstract available
    
    

31. CARIAS DOMINGUEZ AM, de Jesus Rosa Salazar D, Stefanolo JP, Cruz Serrano MC, et al
    Intestinal Dysbiosis: Exploring Definition, Associated Symptoms, and Perspectives for a Comprehensive Understanding - a Scoping Review.
    Probiotics Antimicrob Proteins. 2024 Sep 5. doi: 10.1007/s12602-024-10353.
    PubMed    
    Abstract available
    
    

32. CARA KC, Taylor SF, Alhmly HF, Wallace TC, et al
    The effects of vitamin D intake and status on symptom severity and quality-of-life in adults with irritable bowel syndrome (IBS): a systematic review and meta-analysis.
    Crit Rev Food Sci Nutr. 2024 Sep 5:1-14. doi: 10.1080/10408398.2024.2400603.
    PubMed    
    Abstract available
    
    

33. SILVA A, Temido MJ, Madeira J, Sant'Anna M, et al
    Ulcerative colitis in remission symptoms: a response to anxiety or ongoing inflammation?
    Rev Esp Enferm Dig. 2024;119.
    PubMed    
    Abstract available
    
    

34. RHEE A, Granville Smith I, Compte R, Vehof J, et al
    Quantitative sensory testing and chronic pain syndromes: a cross-sectional study from TwinsUK.
    BMJ Open. 2024;14:e085814.
    PubMed    
    Abstract available
    
    

35. LI J, O'Toole PW
    Disease-associated microbiome signature species in the gut.
    PNAS Nexus. 2024;3:pgae352.
    PubMed    
    Abstract available
    
    

36. ROTH B, Ohlsson B
    Overweight and vitamin D deficiency are common in patients with irritable bowel syndrome - a cross-sectional study.
    BMC Gastroenterol. 2024;24:296.
    PubMed    
    Abstract available
    
    

37. TAO J, Li H, Jin M, Shen W, et al
    Excretion characteristics of main compounds of Yigong San in urine, feces, and bile of rats.
    Biomed Chromatogr. 2024 Sep 3:e5997. doi: 10.1002/bmc.5997.
    PubMed    
    Abstract available
    
    

38. SOHEILIPOUR M, Chermahini TG, Tamizifar B, Kassaian N, et al
    Relative Frequency of Gastrointestinal Functional Disorders in Patients with Inflammatory Bowel Disease Based on Rome IV: A Case-Control Study.
    Adv Biomed Res. 2024;13:43.
    PubMed    
    Abstract available
    
    

39. DAS T, Rimti FH, Fahid HA, Uthso NA, et al
    Prevalence of IBS and its association with academic stress and dormitory lifestyle among medical students of Bangladesh: A cross-sectional study.
    Heliyon. 2024;10:e36259.
    PubMed    
    Abstract available
    
    

40. LACY BE, Xu Y, Taylor DCA, Kosch KJ, et al
    Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United States.
    Neurogastroenterol Motil. 2024 Sep 2:e14903. doi: 10.1111/nmo.14903.
    PubMed    
    Abstract available
    
    

41. LUO M, Wang Y, Huang J, Li Y, et al
    Using PRECIS-2 in Chinese herbal medicine randomized controlled trials for irritable bowel syndrome: A methodological exploration based on literature.
    Integr Med Res. 2024;13:101053.
    PubMed    
    Abstract available
    
    

42. WALTERS JRF, Sikafi R
    Managing bile acid diarrhea: aspects of contention.
    Expert Rev Gastroenterol Hepatol. 2024.
    PubMed    
    Abstract available
    
    

43. CRAWFORD G, Taylor R, Young D, Hatton CG, et al
    Efficacy of the Enteroadsorbent Silicol(R)gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study.
    Gastroenterol Res Pract. 2023;2023:3432763.
    PubMed    
    Abstract available
    
    

44. FAN W, Liu YL, Jiang CH, Wu HY, et al
    Association between psychiatric disorders and irritable bowel syndrome: A bidirectional Mendelian randomization study.
    J Affect Disord. 2024 Sep 9:S0165-0327(24)01515.
    PubMed    
    Abstract available
    
    

45. POP A, Popa SL, Pop DD, Ismaiel A, et al
    Self-Perceived Lactose Intolerance Versus Confirmed Lactose Intolerance in Irritable Bowel Syndrome: A Systematic Review.
    J Gastrointestin Liver Dis. 2024 Sep 9. doi: 10.15403/jgld-5836.
    PubMed    
    Abstract available
    
    

46. MURPHY R, Moots RJ, Brogan P, Celik AF, et al
    British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behcets 2024.
    Br J Dermatol. 2024 Sep 10:ljae263. doi: 10.1093.
    PubMed    
    
    
    

47. GAO S, Tian R
    Mendelian insights: Irritable bowel syndrome as a predictor of upper urinary tract calculi.
    Medicine (Baltimore). 2024;103:e39524.
    PubMed    
    Abstract available
    
    

48. WANG Y, Bi Y, Wang Y, Ji F, et al
    Genetic estimation of causalities between educational attainment with common digestive tract diseases and the mediating pathways.
    BMC Gastroenterol. 2024;24:304.
    PubMed    
    Abstract available
    
    

49. SANGALLI L, Banday F, Sullivan A, Anjum K, et al
    Systemic Factors Affecting Prognosis and Outcomes in Periodontal Disease.
    Dent Clin North Am. 2024;68:571-602.
    PubMed    
    Abstract available
    
    

50. PEARSON C
    Irritable bowel syndrome: an urgent issue.
    Lancet Gastroenterol Hepatol. 2024;9:910.
    PubMed    
    
    
    

51. LI J, Ghosh TS, Arendt E, Shanahan F, et al
    Cross-Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment.
    Adv Sci (Weinh). 2024 Sep 7:e2308313. doi: 10.1002/advs.202308313.
    PubMed    
    Abstract available
    
    

52. JONES ASK, Harding S, Seaton N, Hudson JL, et al
    A real-world longitudinal study implementing digital screening and treatment for distress in inflammatory bowel disease (IBD): The COMPASS-IBD study protocol.
    Contemp Clin Trials. 2024;145:107658.
    PubMed    
    Abstract available
    
    

53. LUPIANEZ-MERLY C, Dilmaghani S, Jencks K, Eckert D, et al
    Additional criteria on scintigraphic testing for diagnosis of rapid colonic transit in patients with chronic diarrhea.
    Neurogastroenterol Motil. 2024 Sep 20:e14917. doi: 10.1111/nmo.14917.
    PubMed    
    Abstract available
    
    

54. ZHANG H, Xiong Z, He Y, Su H, et al
    Cimifugin improves intestinal barrier dysfunction by upregulating SIRT1 to regulate the NRF2/HO-1 signaling pathway.
    Naunyn Schmiedebergs Arch Pharmacol. 2024.
    PubMed    
    Abstract available
    
    

55. PAN YJ, Lin MC, Liou JM, Fan CC, et al
    A population-based study of familial coaggregation and shared genetic etiology of psychiatric and gastrointestinal disorders.
    Commun Med (Lond). 2024;4:180.
    PubMed    
    Abstract available
    
    

56. BANERJEE S, Miriam Abraham L, Gopakumar R, Harithasree L, et al
    Does irritable bowel syndrome plague our budding doctors? - A study from an Indian medical college.
    J Educ Health Promot. 2024;13:216.
    PubMed    
    Abstract available
    
    

57. BAIG M, Gazzaz ZJ, Alyoubi WE, AlMaslamani NW, et al
    Knowledge, Awareness, and Prevalence of Irritable Bowel Syndrome in the Saudi Community: A Cross-Sectional Study.
    Cureus. 2024;16:e67160.
    PubMed    
    Abstract available
    
    

58. LO SW, Hung TH, Lin YT, Lee CS, et al
    Clinical efficacy and safety of faecal microbiota transplantation in the treatment of irritable bowel syndrome: a systematic review, meta-analysis and trial sequential analysis.
    Eur J Med Res. 2024;29:464.
    PubMed    
    Abstract available
    
    

59. WENG C, Xu J, Ying X, Sun S, et al
    The PDIA3-STAT3 protein complex regulates IBS formation and development via CTSS/MHC-II pathway-mediated intestinal inflammation.
    Heliyon. 2024;10:e36357.
    PubMed    
    Abstract available
    
    

60. THAKUR ER, Shapiro JM, Wellington J, Sohl SJ, et al
    A systematic review of yoga for the treatment of gastrointestinal disorders.
    Neurogastroenterol Motil. 2024 Sep 17:e14915. doi: 10.1111/nmo.14915.
    PubMed    
    Abstract available
    
    

61. CARANFIL C, Lorenzon G, Barberio B, Ramonda R, et al
    Inflammatory bowel diseases and spondyloarthritis: a focus on female patients.
    Reumatismo. 2024;76.
    PubMed    
    Abstract available
    
    

62. ZHOU L, Luo D, Lu W, Han J, et al
    Gastrointestinal tract organoids as novel tools in drug discovery.
    Front Pharmacol. 2024;15:1463114.
    PubMed    
    Abstract available
    
    

63. JINDAL N, Jena A, Kumar K, Padhi BK, et al
    Hindi translation and validation of the English version of the gastrointestinal symptom rating scale questionnaire: An observational study.
    World J Gastrointest Pharmacol Ther. 2024;15:97261.
    PubMed    
    Abstract available
    
    

64. ALJAALY EA, Khatib MA
    Translation process of the tested Rome IV diagnostic questionnaire for functional gastrointestinal disorders into Saudi-Arabian Arabic: A mixed-methods approach.
    Pak J Med Sci. 2024;40:1682-1689.
    PubMed    
    Abstract available
    
    

65. BRAVATA DM, Liu H, Colosimo MM, Bullock AC, et al
    Improvements in Digestive Symptoms After Participation in an App-Based Chronic Digestive Disease Management Program: A Prospective Cohort Evaluation.
    Cureus. 2024;16:e66941.
    PubMed    
    Abstract available
    
    

66. DJATIOETOMO AK, Maharani AR, Djatioetomo YC, Nurrochmawati Z, et al
    Low-FODMAP diet on postprandial distress syndrome type of functional dyspepsia with mixed type of irritable bowel syndrome patient: A case report.
    Narra J. 2024;4:e759.
    PubMed    
    Abstract available
    
    

67. CHEN XL, Jiang MZ
    [Research progress of metabolomics in children with irritable bowel syndrome].
    Zhongguo Dang Dai Er Ke Za Zhi. 2024;26:989-994.
    PubMed    
    Abstract available
    
    

68. ROTH B, Nseir M, Jeppsson H, D'Amato M, et al
    A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS-A Randomized Non-Inferiority Study.
    Nutrients. 2024;16:3039.
    PubMed    
    Abstract available
    
    

69. IONESCU VA, Gheorghe G, Georgescu TF, Bacalbasa N, et al
    The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome.
    J Clin Med. 2024;13:5124.
    PubMed    
    Abstract available
    
    

70. GUIDO D, Maqoud F, Aloisio M, Mallardi D, et al
    Transcriptomic Module Discovery of Diarrhea-Predominant Irritable Bowel Syndrome: A Causal Network Inference Approach.
    Int J Mol Sci. 2024;25:9322.
    PubMed    
    Abstract available
    
    

71. WU X, Cao Y, Liu Y, Zheng J, et al
    A New Strategy for Dietary Nutrition to Improve Intestinal Homeostasis in Diarrheal Irritable Bowel Syndrome: A Perspective on Intestinal Flora and Intestinal Epithelial Interaction.
    Nutrients. 2024;16:3192.
    PubMed    
    Abstract available
    
    

72. CHOI NR, Ko SJ, Nam JH, Choi WG, et al
    Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5.
    Pharmaceuticals (Basel). 2024;17:1170.
    PubMed    
    Abstract available
    
    

73. PEREZ-CABRAL ID, Bernal-Mercado AT, Islas-Rubio AR, Suarez-Jimenez GM, et al
    Exploring Dietary Interventions in Autism Spectrum Disorder.
    Foods. 2024;13:3010.
    PubMed    
    Abstract available
    
    

74. KWON H, Nam EH, Kim H, Jo H, et al
    Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial.
    Sci Rep. 2024;14:22384.
    PubMed    
    Abstract available
    
    

75. ABOU CHAAYA J, Abou Chaaya J, Jaafar B, Saab L, et al
    Morphological Changes of the Pituitary Gland in Patients with Irritable Bowel Syndrome Using Magnetic Resonance Imaging.
    J Imaging. 2024;10:226.
    PubMed    
    Abstract available
    
    

76. PIONTKOWSKI AJ, Sharma D, Ungar B
    Rosacea and gastrointestinal diseases: A case-control study in the All of Us database.
    Dermatology. 2024 Sep 26:1-9. doi: 10.1159/000541469.
    PubMed    
    Abstract available
    
    

77. LUCCA LC, Brusamarello NP, Fornari F
    Translational evaluation of Gelsectan(R) effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhea.
    United European Gastroenterol J. 2024 Sep 26. doi: 10.1002/ueg2.12681.
    PubMed    
    
    
    

78. COOMBES BJ, Sanchez-Ruiz JA, Fennessy B, Pazdernik VK, et al
    Clinical associations with treatment resistance in depression: An electronic health record study.
    Psychiatry Res. 2024;342:116203.
    PubMed    
    Abstract available
    
    

79. GARVEY SM, LeMoire A, Wang J, Lin L, et al
    Safety and Tolerability of Microbial Inulinase Supplementation in Healthy Adults: A Randomized, Placebo-Controlled Trial.
    Gastro Hep Adv. 2024;3:920-930.
    PubMed    
    Abstract available
    
    

80. GOLOB J, Rao K, Berinstein JA, Singh P, et al
    Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways.
    medRxiv [Preprint]. 2024 Sep 9:2024.09.08.24313266.
    PubMed    
    Abstract available
    
    

81. BALSIGER LM, Rusticeanu M, Langhorst J, Sina C, et al
    Review: Food-induced mucosal alterations visualized using endomicroscopy.
    Neurogastroenterol Motil. 2024 Sep 24:e14930. doi: 10.1111/nmo.14930.
    PubMed    
    Abstract available
    
    

82. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    The neurotensin receptor 1 agonist PD149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model.
    Neurogastroenterol Motil. 2024 Sep 24:e14925. doi: 10.1111/nmo.14925.
    PubMed    
    Abstract available
    
    

83. SHIN A
    Disorders of gastric motility.
    Lancet Gastroenterol Hepatol. 2024 Sep 20:S2468-1253(24)00231.
    PubMed    
    Abstract available
    
    

84. LIN Y, He J, Ding Z
    Sedentary and 21 gastrointestinal disorders: A Mendelian randomization study.
    Medicine (Baltimore). 2024;103:e39813.
    PubMed    
    Abstract available
    
    

85. WANG B, Cheng P, Jin B, Jiang Y, et al
    Effect of Tryptophan Restriction in the Therapy of Irritable Bowel Syndrome: a Systematic Review.
    Int J Gen Med. 2024;17:4141-4151.
    PubMed    
    Abstract available
    
    

86. SHAHKARAM H, Sadeghi A, Masjedi Arani A, Bakhtiari M, et al
    Comparing the effectiveness of online individualized transdiagnostic treatment with acceptance and commitment therapy on medication adherence, gastrointestinal symptoms and perceived stress of patients with irritable bowel syndrome.
    Gastroenterol Hepatol Bed Bench. 2024;17:288-296.
    PubMed    
    Abstract available
    
    

87. MARTINEZ BURGOS M, Villena-Salinas J, Martinez Oton JA, Gallego Peinado M, et al
    Initiation of SeHCAT(R) Protocol in a digestive service: a further step in the management of chronic diarrhoea.
    Rev Esp Enferm Dig. 2024 Sep 19. doi: 10.17235/reed.2024.10788/2024.
    PubMed    
    Abstract available
    
    

88. SHIN A
    Editorial: Disordered eating and irritable bowel syndrome-Do maladaptive eating and weight control behaviours increase risk of a maladaptive gut?
    Aliment Pharmacol Ther. 2024 Aug 28. doi: 10.1111/apt.18232.
    PubMed    
    
    
    

89. KERBAGE A, Loesch J, Hamza E, Khan S, et al
    Evaluating Equity in Clinical Trial Accessibility: An Analysis of Demographic, Socioeconomic, and Educational Disparities in IBS Drug Trials.
    Am J Gastroenterol. 2024 Sep 24. doi: 10.14309/ajg.0000000000003099.
    PubMed    
    Abstract available
    
    

90. BOSMAN M, Vork L, Jonkers D, Snijkers J, et al
    Results from a psychometric validation study: irritable bowel syndrome patients report higher symptom burden using end-of-day versus real-time assessment.
    Am J Gastroenterol. 2024 Sep 23. doi: 10.14309/ajg.0000000000003091.
    PubMed    
    Abstract available
    
    

91. GROVER M, Vanuytsel T, Chang L
    Intestinal permeability in disorders of gut-brain interaction (DGBI): From bench to bedside.
    Gastroenterology. 2024 Sep 3:S0016-5085(24)05416.
    PubMed    
    Abstract available
    
    

92. LIU WQ, Shu L, Zhou X, Wang XF, et al
    Evaluation of the efficacy of polyethylene glycol in combination with different doses of linaclotide in a fractionated bowel preparation for colonoscopy: a prospective randomized controlled study.
    Int J Colorectal Dis. 2024;39:143.
    PubMed    
    Abstract available
    
    

93. PENG D, Yang S, Zhai H
    The causal relationship between cholecystectomy and IBD/IBS and the role of bile acids and gut microbiota: a two-sample Mendelian randomization study.
    Int J Colorectal Dis. 2024;39:149.
    PubMed    
    Abstract available
    
    

94. KIP M, Kaya N, Capar AG
    Is orthorexia nervosa a hidden threat impacting quality of life in IBS patients?
    Ir J Med Sci. 2024 Sep 17. doi: 10.1007/s11845-024-03805.
    PubMed    
    Abstract available
    
    

95. CHEN G, Wu X, Zhu H, Li K, et al
    Multisample lipidomic profiles of irritable bowel syndrome and irritable bowel syndrome-like symptoms in patients with inflammatory bowel disease: new insight into the recognition of the same symptoms in different diseases.
    J Gastroenterol. 2024 Sep 10. doi: 10.1007/s00535-024-02148.
    PubMed    
    Abstract available
    
    

96. SAINI U, Rosmalen JGM, Oldehinkel AJ, van Loo HM, et al
    Connecting the dots: Network structures of internalizing and functional symptoms in a population-based cohort.
    J Psychosom Res. 2024;187:111932.
    PubMed    
    Abstract available
    
    

97. RZESZUTEK M, Kowalkowska J, Drabarek K, Van Hoy A, et al
    Adverse childhood experiences and alexithymia intensity as predictors of temporal dynamics of functioning in individuals with irritable bowel syndrome: A three-wave latent transition analysis.
    J Psychosom Res. 2024;187:111904.
    PubMed    
    Abstract available
    
    

98. DALE HF, Hagen M, Bekkelund M, Deb C, et al
    Disaccharidase deficiencies and gastrointestinal symptoms in patients referred to gastroscopic examination: a single center study from Norway.
    Scand J Gastroenterol. 2024 Sep 4:1-6. doi: 10.1080/00365521.2024.2395848.
    PubMed    
    Abstract available